|
All Business Categories
|
aaiPharma Inc.
North Carolina, USA AAIPharma Inc. is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. From a single test through a ran... Axcan Pharma Inc. Quebec, Canada Axcan is a leading specialty pharmaceutical company involved in the field of gastroenterology. The Company markets a broad line of prescription products sold for the treatment of s... NUCRYST Pharmaceuticals Corp. Massachusetts, USA NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically diso... Organon Inc. New Jersey, USA Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business part... Inyx , Inc. Florida, USA ITEM 1. DESCRIPTION OF BUSINESS General Inyx, Inc. (Inyx, we, us, our, or the Company), through its wholly-owned subsidiaries, Inyx Pharma Limited (Inyx Pharma), Inyx C... Minnesota, USA MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products that address the unme... Eisai Inc. New Jersey, USA Information about Eisai pharmaceuticals prescription drugs in Oncology include: ONTAK, Targretin capsules, Targretin gel, and Panretin gel. Eisai also markets Aricept, Cerebyx, Zon... SkyePharma PLC London, United Kingdom SkyePharma PLC develops pharmaceutical products benefiting from world-leading Lannett Company , Inc. Pennsylvania, USA Lannett Company, Inc manufactures and distributes pharmaceutical products sold under generic names, and historically, has sold them under trade or brand names as well. The Company'... Par Pharmaceutical Companies , Inc. NEW, USA Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In 2005, Par received approval for...
First
Prev
[1]
[2]
[3]
[4]
[5]
[6]
7
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[78]
[137]
[196]
Next
Last
|
